Delivery Order SPE2DB22D2007-SPE2DB24FJ3UP
Award Date
6/28/24
Potential Completion Date
7/22/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $7,641.98 for the supply of NUBEQA 300 MG TABLET 120S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract, valued at $3,518.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a federal agency within the Department of Defense. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $7,036.80 for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a completion date of July 22, 2024 and was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,071,825 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The delivery order, valued at $3,518.40, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,518.40, is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $7,036.80, is for the delivery of NUBEQA 300 MG TABLET 120S. The contract is a Delivery Order, with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract is not set aside and does not appear to be associated with a larger vehicle. However, Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,518.40 firm fixed-price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through March 21, 2024. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $3,518.40 and a performance period through May 3, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This federal contract award, valued at $10,555.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUBEQA 300 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...